找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drugs and the Liver: High Risk Patients and Transplantation; D. Galmarini,L. R. Fassati,S. Sherlock Book 1993 Springer Science+Business Me

[復(fù)制鏈接]
樓主: 實(shí)體
31#
發(fā)表于 2025-3-27 00:00:39 | 只看該作者
DSC Configuration Delivery Modesration, because it represents a potentially irreversible form of injury, for which there is little available therapy (1). In the recent past, this specific area of investigation has significantly progressed and the molecular biology techniques are the basis for this terrific improvement (2).
32#
發(fā)表于 2025-3-27 05:05:28 | 只看該作者
33#
發(fā)表于 2025-3-27 06:17:08 | 只看該作者
978-94-010-5748-6Springer Science+Business Media Dordrecht 1993
34#
發(fā)表于 2025-3-27 11:41:51 | 只看該作者
Medical Science Symposia Serieshttp://image.papertrans.cn/e/image/283213.jpg
35#
發(fā)表于 2025-3-27 15:38:11 | 只看該作者
36#
發(fā)表于 2025-3-27 20:34:24 | 只看該作者
Risk Assessment in Liver Transplantation Focus on Lung Function, transplanted patients and these organs may fail even when the liver function is acceptable. Renal, hemodynamic and cardiac function, coagulation abnormalities have been extensively investigated in this context while lung function is less frequently addressed.
37#
發(fā)表于 2025-3-27 22:30:02 | 只看該作者
Donor Rating and Assessment of Pretransplant Prognosis by Use of the MEGX Test,formation of the lidocaine metabolite monoethylglycinexylidide (MEGX). This test is rapid and easy to perform. A loss of hepatic cytochrome P-450 activity or major changes of hepatic blood flow, for instance due to portosystemic shunting, result in a decrease of MEGX formation.
38#
發(fā)表于 2025-3-28 05:27:15 | 只看該作者
39#
發(fā)表于 2025-3-28 06:35:25 | 只看該作者
Bacteremia After Liver Transplantation; Few Issues in Selection of Antibiotics for Treatment and Prs. Bacteremia represents “invasive” infection and knowing the common agents involved helps in selection of antibiotics for treatment and prophylaxis. Successful use of antibiotics requires familiarity with their characteristics, potential side effects and interactions with other medications.
40#
發(fā)表于 2025-3-28 10:47:10 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 12:38
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
永胜县| 乌什县| 化隆| 舟山市| 汨罗市| 金坛市| 大连市| 大城县| 渝中区| 永春县| 保德县| 镇雄县| 丰县| 方城县| 肃南| 永济市| 彭州市| 阜新| 双城市| 陆河县| 佛坪县| 江都市| 镇雄县| 盐池县| 九江县| 宁南县| 天峻县| 大安市| 余干县| 潼南县| 濮阳县| 贵港市| 图们市| 天峻县| 洛南县| 台南县| 信阳市| 桂东县| 高州市| 平远县| 武鸣县|